Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 2,500 shares at $0.15 ($375) on 2016-10-05, disclosed to the SEC on 2016-10-06.
Seasonal purchase ($375) by CEO, 10% Owner — this insider has traded LXRP in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| LXRP | BUY | 2016-10-11 | $3K | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |
| LXRP | BUY | 2016-08-25 | $3K | — | Filing → |